Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 23
2005 34
2006 36
2007 47
2008 47
2009 53
2010 46
2011 62
2012 65
2013 59
2014 49
2015 40
2016 44
2017 56
2018 58
2019 45
2020 52
2021 57
2022 47
2023 43
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

882 results

Results by year

Filters applied: . Clear all
Page 1
Drug safety evaluation of aripiprazole in bipolar disorder.
Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A. Cuomo A, et al. Expert Opin Drug Saf. 2019 Jun;18(6):455-463. doi: 10.1080/14740338.2019.1617847. Epub 2019 May 17. Expert Opin Drug Saf. 2019. PMID: 31072228 Review.
Introduction: Safety and tolerability of medications are key variables to inform treatment choice for patients with bipolar disorder (BD). This review focuses on the overall tolerability and safety profile of aripiprazole when used for its bipolar disorder in …
Introduction: Safety and tolerability of medications are key variables to inform treatment choice for patients with bipolar disorder …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vazquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, O'Donovan C, Tourjman V, Kozicky JM, Kauer-Sant'Anna M, Malhi G, Suppes T, Vieta E, Kapczinski F, Kanba S, Lam RW, Kennedy SH, Calabrese J, Berk M, Post R. Yatham LN, et al. Bipolar Disord. 2021 Dec;23(8):767-788. doi: 10.1111/bdi.13135. Epub 2021 Nov 1. Bipolar Disord. 2021. PMID: 34599629 Review.
OBJECTIVES: The 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided clinicians with pragmatic treatment recommendations for bipolar disorder (BD). ...For DSM-IV defined mixed episo …
OBJECTIVES: The 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) …
Aripiprazole.
[No authors listed] [No authors listed] 2023 Jun 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2023 Jun 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643195 Free Books & Documents. Review.
Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and bipolar illness. Aripiprazole therapy has not been associated consistently with serum aminotransferase elevations and has yet to be linked to cases of clinically apparent acu
Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and bipolar illness. Aripiprazole ther
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N. Kishi T, et al. Mol Psychiatry. 2022 Feb;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. Epub 2021 Oct 12. Mol Psychiatry. 2022. PMID: 34642461 Free PMC article.
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, quetiapine, risperidone, tamoxifen, valproate, and ziprasidone outperformed the improvement of mania symptoms (N = 61, n = 15466), and aripipr
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, queti …
The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review.
Muneer A. Muneer A. Cureus. 2016 Apr 7;8(4):e562. doi: 10.7759/cureus.562. Cureus. 2016. PMID: 27190727 Free PMC article. Review.
Aripiprazole is a novel antipsychotic initially approved for the treatment of schizophrenia but soon found to be effective in bipolar disorder. ...The current review summarizes the data from controlled trials regarding the efficacy and safety of aripiprazole
Aripiprazole is a novel antipsychotic initially approved for the treatment of schizophrenia but soon found to be effective in bipo
Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review.
Roosen L, Sienaert P. Roosen L, et al. J Affect Disord. 2022 Aug 15;311:69-77. doi: 10.1016/j.jad.2022.05.017. Epub 2022 May 8. J Affect Disord. 2022. PMID: 35545157 Review.
Lithium, anticonvulsants, second generation antipsychotics, antidepressants and thyroid hormone were assessed as treatment options in the presented data. Evidence supporting the use of aripiprazole, olanzapine, quetiapine, valproate and lamotrigine for treatment of rapid c …
Lithium, anticonvulsants, second generation antipsychotics, antidepressants and thyroid hormone were assessed as treatment options in the pr …
Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults.
Aggarwal A, Schrimpf L, Lauriello J. Aggarwal A, et al. Clin Schizophr Relat Psychoses. 2018 Jan;11(4):221-223. doi: 10.3371/CSRP.AGSC.010318. Clin Schizophr Relat Psychoses. 2018. PMID: 29341822 Review.
Bipolar I disorder is a serious and disabling psychiatric illness. ...In this paper we discuss the available data for safety and efficacy of aripiprazole long-acting injectable in bipolar disorder....
Bipolar I disorder is a serious and disabling psychiatric illness. ...In this paper we discuss the available data for safety and effi
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.
Li DJ, Tseng PT, Stubbs B, Chu CS, Chang HY, Vieta E, Fornaro M, Carvalho AF, Solmi M, Veronese N, Chen TY, Chen YW, Lin PY, Chow PC. Li DJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):289-301. doi: 10.1016/j.pnpbp.2017.06.023. Epub 2017 Jun 23. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 28651936 Review.
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehensive meta-analysis to investigate the efficacy and safety profile of aripiprazole in treating BD. ...Aripiprazole was associa …
Numerous studies have investigated aripiprazole as a treatment for bipolar disorder (BD). therefore we conducted this comprehe …
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS. McIntyre RS. Clin Ther. 2010;32 Suppl 1:S32-8. doi: 10.1016/j.clinthera.2010.01.022. Clin Ther. 2010. PMID: 20152551 Review.
Few pharmacologic agents have been approved by the US Food and Drug Administration for the maintenance treatment of bipolar disorder. OBJECTIVE: This paper discusses the metabolic profile of aripiprazole and reviews pivotal registration trials of aripiprazole
Few pharmacologic agents have been approved by the US Food and Drug Administration for the maintenance treatment of bipolar disorder. …
Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents.
Kirino E. Kirino E. Adolesc Health Med Ther. 2014 Nov 27;5:211-21. doi: 10.2147/AHMT.S50015. eCollection 2014. Adolesc Health Med Ther. 2014. PMID: 25473324 Free PMC article. Review.
The presently reviewed randomized controlled trials (RCTs) and non-RCTs generally reported aripiprazole to be effective and well-tolerated in children and adolescents with bipolar disorder. However, due to the limited number of RCTs, the present conclusions must be …
The presently reviewed randomized controlled trials (RCTs) and non-RCTs generally reported aripiprazole to be effective and well-tole …
882 results